NCT00001766View on ClinicalTrials.gov

Drug Interactions Among Anti-HIV Agents

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

August 31, 1998

Study Completion Date

August 31, 2003

Conditions
HIV Infection
Interventions
DRUG

Amprenavir, Efavirenz, Abacavir, Nelfinavir, Ritonavir

Trial Locations (1)

20892

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00001766 - Drug Interactions Among Anti-HIV Agents | Biotech Hunter | Biotech Hunter